Home > Insider Trading > Filing (0001209191-20-039435)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
879169	Incyte Corp	INCY	Services-Commercial Physical & Biological Research (8731)	943136539

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1596492	Herve Hoppenot	1801 Augustine Cut-Off Wilmington DE 19803	Chairman / Ceo	Yes	Yes	No	Yes

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-06-26	4,647	$64.55	245,250	No	4	M	Direct
Common Stock	Disposition	2020-06-26	4,647	$102.91	240,603	No	4	S	Direct
Common Stock	Acquisiton	2020-06-26	119,501	$64.55	360,104	No	4	M	Direct
Common Stock	Disposition	2020-06-26	119,501	$102.91	240,603	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Incentive Stock Option (right to buy)	Disposition	2020-06-26	4,647	$0.00	4,647	$64.55
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2020-06-26	119,501	$0.00	119,501	$65.55

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2021-01-20	No	4	M	Direct
0		2021-01-20	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	66,234	Indirect	By GRAT
Common Stock	66,234	Indirect	By GRAT
Common Stock	66,234	Indirect	By GRAT
Common Stock	66,234	Indirect	By GRAT

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
Represents weighted average sale price. Actual sale prices ranged from $101.25 - $105.56.
This includes an aggregate of 107,977 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested.
On June 15, 2018, the reporting person contributed 103,033 shares to a grantor retained annuity trust (GRAT). On June 17, 2019, 20,407 shares were distributed by the GRAT to the reporting person in accordance with the terms of the GRAT and continue to be reported in this Form 4 as directly owned. In addition, on June 2, 2020 an additional 16,392 were distributed by the GRAT to the reporting person in accordance with the terms of the GRAT and continue to be reported in this Form 4 as directly owned.
Beginning January 21, 2014, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.